Bjørgo E, Ånensen N, Fagereng GL, Russnes HG, Smeland S, Taskén K, Helland Å(2026) Merging clinical research and standard healthcare - Nordic Precision Cancer Medicine Symposium 2025 Acta Oncol, 65, 181-185 DOI 10.2340/1651-226X.2026.45168, PubMed 41778669
Martin Agudo M, Van der Pol H, Bratseth Stav G, Kringelbach T, Puco K, Flobak Å, Gelderblom H, Taskén K, Fagereng GL, Hovig E, PRIME-ROSE Consortium(2026) 'Crossing borders' in data standardisation: application of OMOP CDM in an international clinical trial network in precision cancer medicine Acta Oncol, 65, 159-163 DOI 10.2340/1651-226X.2026.45120, PubMed 41733536
Frisell O, Aas E, Henkel PS, Fagereng GL, Taskén K, Hallersjö Hult E, Lindgren P, Steen Carlsson K(2026) A conceptual health economic modelling framework to assess the cost-effectiveness of molecular target-driven treatment regimens in oncology Acta Oncol, 65, 141-147 DOI 10.2340/1651-226X.2026.45088, PubMed 41711494